Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Key results from Calocurb's fourth human clinical study include the following: Calocurb is clinically shown to improve body composition by reducing body fat without losing muscle mass Average weight loss of 8.3 lbs (3.77 kg) after six months, compared to 0.88 lbs (0.4 kg) with the placebo group Over 6.5x greater reduction in body fat vs placebo Average body fat loss of 9.9 lbs (4.49 kg) vs 1.5 lbs (0.68 kg) after six months of consistent use of Calocurb vs placebo 3.5x greater reduction in visceral fat vs placebo Average visceral fat loss of 5 in2 (32.5 cm2) vs 1.4 in2 (9.1 cm2) lost after six months of consistent use of Calocurb vs placebo For over a decade, Calocurb has undertaken ground-breaking clinical research into Amarasate to continue bringing natural weight management solutions to those interested in GLP-1 and weight loss options.
In the Phase 3 TRIUMPH-1 trial reported May 21, 2026, the 12 mg arm produced mean body-weight reduction of 28.3% at 80 weeks, with extension data reaching 30.3% at 104 weeks [1][2]
PlexusDx charges a flat $189 per month for Semaglutide Injection regardless of dose levelyour price stays the same whether you escalate quickly or gradually
In mouse models, infusion of GIP was found to have anti-atherogenic effects
Always check with your pharmacy about the exact concentrations in your vial
